AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
OSAKA, June 2 Asia Pulse - Takara Bio Inc., which is under the wing of Takara Holdings Inc. (TSE:2531), has begun developing a device that would facilitate the detection of the SARS virus, company sources said.
The compact device is intended for bedside use, for example, because it does not require use of a large machine.
The company plans to market the product by the end of this year.
The device makes it possible to tell whether patients have been infected with the SARS virus by mixing the genes in their phlegm with a reagent and analyzing the results.
...
Source: HighBeam Research, JAPAN'S TAKARA BIO DEVELOPING COMPACT SARS DIAGNOSIS KIT.